ACM
Aster Capital Management Portfolio holdings
AUM
$441M
1-Year Return
16.94%
This Quarter Return
+2.68%
1 Year Return
+16.94%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
-$200M
(-43%)
Cap. Flow
-$203M
Cap. Flow
% of AUM
-77.44%
Top 10 Holdings %
Top 10 Hldgs %
21.87%
Holding
1,621
New
546
Increased
210
Reduced
264
Closed
543
Top Buys
| 1 |
iShares US Real Estate ETF
IYR
|
+$8.63M |
| 2 |
Meta Platforms (Facebook)
META
|
+$8.45M |
| 3 |
Broadcom
AVGO
|
+$6.97M |
| 4 |
Apple
AAPL
|
+$4.91M |
| 5 |
SPDR S&P Homebuilders ETF
XHB
|
+$4.79M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$24.5M |
| 2 |
Microsoft
MSFT
|
+$16.3M |
| 3 |
NVIDIA
NVDA
|
+$11.3M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$10.9M |
| 5 |
iShares Semiconductor ETF
SOXX
|
+$8.77M |
Sector Composition
| 1 | Financials | 18.24% |
| 2 | Technology | 15.35% |
| 3 | Consumer Discretionary | 10.57% |
| 4 | Industrials | 8.9% |
| 5 | Communication Services | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Extreme Networks
EXTR
$2.95B
| $5.22K | ﹤0.01% |
+312
| New | +$5.22K |
|
|
ALEX
852
Alexander & Baldwin
ALEX
$1.37B
| $5.22K | ﹤0.01% |
294
-88
| -23% | -$1.56K |
|
|
UMH
853
UMH Properties
UMH
$1.26B
| $5.19K | ﹤0.01% |
275
-317
| -54% | -$5.99K |
|
854
Redwire
RDW
$1.18B
| $5.15K | ﹤0.01% |
+313
| New | +$5.15K |
|
855
ImmunityBio
IBRX
$2.42B
| $5.13K | ﹤0.01% |
+2,004
| New | +$5.13K |
|
856
Marten Transport
MRTN
$937M
| $5.09K | ﹤0.01% |
326
-455
| -58% | -$7.1K |
|
857
Summit Therapeutics
SMMT
$13.1B
| $5K | ﹤0.01% |
280
+83
| +42% | +$1.48K |
|
858
Acadia Healthcare
ACHC
$2B
| $5K | ﹤0.01% |
+126
| New | +$5K |
|
|
SOWG
859
Sow Good
SOWG
$9.43M
| $4.98K | ﹤0.01% |
2,439
| – | – |
|
860
Fluence Energy
FLNC
$900M
| $4.89K | ﹤0.01% |
+308
| New | +$4.89K |
|
861
Viavi Solutions
VIAV
$2.67B
| $4.86K | ﹤0.01% |
+481
| New | +$4.86K |
|
|
VRE
862
Veris Residential
VRE
$1.49B
| $4.81K | ﹤0.01% |
289
-231
| -44% | -$3.84K |
|
863
Celldex Therapeutics
CLDX
$1.64B
| $4.8K | ﹤0.01% |
+190
| New | +$4.8K |
|
864
Four Corners Property Trust
FCPT
$2.7B
| $4.75K | ﹤0.01% |
+175
| New | +$4.75K |
|
865
Daktronics
DAKT
$1.08B
| $4.74K | ﹤0.01% |
+281
| New | +$4.74K |
|
866
89bio
ETNB
$1.25B
| $4.71K | ﹤0.01% |
602
+490
| +438% | +$3.83K |
|
867
Immunovant
IMVT
$2.88B
| $4.71K | ﹤0.01% |
190
-101
| -35% | -$2.5K |
|
868
Travere Therapeutics
TVTX
$2.46B
| $4.69K | ﹤0.01% |
+269
| New | +$4.69K |
|
869
Exact Sciences
EXAS
$10.4B
| $4.66K | ﹤0.01% |
83
-11,016
| -99% | -$619K |
|
870
Cogent Biosciences
COGT
$1.78B
| $4.64K | ﹤0.01% |
595
+482
| +427% | +$3.76K |
|
871
Toast
TOST
$23.2B
| $4.63K | ﹤0.01% |
+127
| New | +$4.63K |
|
872
Nurix Therapeutics
NRIX
$690M
| $4.48K | ﹤0.01% |
+238
| New | +$4.48K |
|
873
Myriad Genetics
MYGN
$640M
| $4.44K | ﹤0.01% |
324
-20,134
| -98% | -$276K |
|
874
PTC Therapeutics
PTCT
$4.64B
| $4.42K | ﹤0.01% |
+98
| New | +$4.42K |
|
875
Varonis Systems
VRNS
$6.31B
| $4.4K | ﹤0.01% |
+99
| New | +$4.4K |
|